Trilaciclib (G1T28) in Patients With Previously Treated Extensive Stage SCLC Receiving Topotecan Chemotherapy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

October 5, 2015

Primary Completion Date

September 28, 2018

Study Completion Date

October 4, 2021

Conditions
Small Cell Lung Cancer
Interventions
DRUG

Trilaciclib

DRUG

Placebo

DRUG

Topotecan

Trial Locations (50)

1000

University Clinic of Radiotherapy and Oncology Skopje, Skopje

2930

AZ Klina, Brasschaat

10000

"University Clinical Hospital Centre Sestre Milosrdnice", Zagreb

University Hospital Centre Zagreb, Clinic For Pulmonary Diseases Jordanovac, Zagreb

11000

Clinic for Pulmology, Clinical Centre of Serbia, Belgrade

Clinical Hospital Centre Bezanijska Kosa, Belgrade

Oncology and Radiology Institute of Serbia, Belgrade

11733

North Shore Hematology Oncology Associates PC, East Setauket

18204

Clinical Center Nis, Clinic for Lung Diseases, Niš

18840

Guthrie Medical Group, PC, Sayre

21204

Institute for Pulmonary Diseases of Vojvodina Clinic for Thoracic Oncology, Kamenitz

22031

Virginia Cancer Specialists, Fairfax

23502

Virginia Oncology Associates, Norfolk

27893

Regional Medical Oncology Center, Wilson

29303

Gibbs Cancer Center, Spartanburg

29605

Greenville Health System, Greenville

29621

AnMed Health, Anderson

30322

Emory University, Atlanta

30341

Northside Hospital - Georgia Cancer Specialists, Atlanta

30607

University Cancer and Blood Center, LLC, Athens

31000

Clinical Hospital Centre Osijek, Osijek

32778

Florida Cancer Specialists - North, Tavares

33916

Florida Cancer Specialists - South, Fort Myers

37208

Meharry Medical College, Nashville

37232

Sarah Cannon Research Institute, Nashville

37920

Hanna Cancer Associates - University of Tennessee, Knoxville

44718

Gabrail Cancer Center, Canton

64111

Saint Luke's Cancer Institute, Kansas City

71000

University Clinical Centre Sarajevo, Sarajevo

71913

Genesis Cancer Center, Hot Springs

72758

Highlands Oncology Group, Rogers

73117

Oklahoma University - Peggy and Charles Stephenson Cancer Center, Oklahoma City

75246

Texas Oncology- Baylor Charles A. Sammons Cancer Center, Dallas

75702

Texas Oncology, Tyler

75708

The University of Texas Health Science Center at Tyler, Tyler

77030

M.D. Anderson, Houston

77090

Millennium Oncology, Houston

78000

University Clinical Centre Banja Luka, Banja Luka

79415

Southwest Cancer Center, Lubbock

80218

Rocky Mountain Cancer Centers, Denver

80528

University of Colorado Health, Oncology Clinical Research Northern Region, Fort Collins

80909

Memorial Hospital - University of Colorado Health, Colorado Springs

90603

The Oncology Institute of Hope and Innovation, Whittier

92879

Compassionate Cancer Care Medical Group, Inc., Corona

95816

Sutter Medical Group, Sacramento

98684

Northwest Cancer Specialists, P.C., Vancouver

03756

Norris Cotton Cancer Center, Lebanon

04191

VOU Department of Radiotherapy and Oncology, Košice

05801

POKO POPRAD, s.r.o., Poprad

Unknown

University Clinic of Respiratory and Allergic Diseases Golnik, Golnik

Sponsors
All Listed Sponsors
lead

G1 Therapeutics, Inc.

INDUSTRY